approval
saveMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 192d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 192d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 531d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 545d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 545d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 19, 2025 · 564d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 564d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 576d ago
same company · ±60 days · 6
- approvalSpexotras: MEKINIST (TRAMETINIB) — FDA approvalOct 1, 2024
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalOct 4, 2024
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalOct 4, 2024
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2024
comments(0)
5-min edit window · permanent after that